SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-22-000136
Filing Date
2022-11-03
Accepted
2022-11-03 08:00:23
Documents
14
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K selb-20221103.htm   iXBRL 8-K 39285
2 EX-99.1 exhibit991_earningsrelease.htm EX-99.1 115325
6 selectalogoa06.jpg GRAPHIC 24765
  Complete submission text file 0001453687-22-000136.txt   332629

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT selb-20221103.xsd EX-101.SCH 1946
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT selb-20221103_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT selb-20221103_pre.xml EX-101.PRE 12548
8 EXTRACTED XBRL INSTANCE DOCUMENT selb-20221103_htm.xml XML 10821
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 221356316
SIC: 2834 Pharmaceutical Preparations